Akin H. Davulcu, Zhongmin Zhu, Jollie D. Godfrey, Mark D. Schwinden, Rita Fox, Bharat P. Patel, Wendel W. Doubleday, and Rodney L. Parsons, Jr. Bristol-Myers Squibb Company, New Brunswick, NJ
The discovery, development and implementation of an efficient, scalable process for the preparation of the tetrazole core of BMS-317180 will be described. Key considerations in the development of this process focused on safety and the requirement for a complex, telescoped sequence to contend with the lack of crystalline intermediates.

Back to Process Chemistry General Session
Back to The Middle Atlantic Regional Meeting (May 16 - 18, 2007)